Skip to main content

EXELIXIS, INC.

For the period ended Jan 2, 2026. Filed Feb 10, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Feb 10, 2026

EXEL$70.58-1.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Income

(in thousands, except per share data)

Year Ended December 31,
202520242023
Revenues:
Net product revenues$2,122,804$1,809,395$1,628,879
Collaboration revenues197,322359,306201,329
Total revenues2,320,1262,168,7011,830,208
Operating expenses:
Cost of goods sold83,69776,21672,547
Research and development825,001910,4081,044,071
Selling, general and administrative518,727492,128542,705
Impairment of long-lived assets—51,672—
Restructuring20,51033,660—
Total operating expenses1,447,9351,564,0841,659,323
Income from operations872,191604,617170,885
Interest income69,21377,15686,543
Other income (expenses), net(198)(133)93
Income before income taxes941,206681,640257,521
Provision for income taxes158,636160,37349,756
Net income$782,570$521,267$207,765
Net income per share:
Basic$2.88$1.80$0.65
Diluted$2.78$1.76$0.65
Weighted-average common shares outstanding:
Basic271,567290,030318,151
Diluted281,863296,132321,464
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.